158 related articles for article (PubMed ID: 24648999)
1. Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.
Xiang Y; Zeng H; Liu X; Zhou H; Luo L; Duan C; Luo X; Yan H
Biomed Rep; 2013 Jul; 1(4):629-637. PubMed ID: 24648999
[TBL] [Abstract][Full Text] [Related]
2. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.
Ning S; Wei W; Li J; Hou B; Zhong J; Xie Y; Liu H; Mo X; Chen J; Zhang L
J Cancer; 2018; 9(3):494-501. PubMed ID: 29483954
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
5. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia.
Szánthó E; Bhattoa HP; Csobán M; Antal-Szalmás P; Újfalusi A; Kappelmayer J; Hevessy Z
PLoS One; 2014; 9(3):e91647. PubMed ID: 24621590
[TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
7. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
8. The proliferation marker thymidine kinase 1 in clinical use.
Zhou J; He E; Skog S
Mol Clin Oncol; 2013 Jan; 1(1):18-28. PubMed ID: 24649117
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
[No Abstract] [Full Text] [Related]
10. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
11. Can thymidine kinase levels in breast tumors predict disease recurrence?
O'Neill KL; Hoper M; Odling-Smee GW
J Natl Cancer Inst; 1992 Dec; 84(23):1825-8. PubMed ID: 1433372
[TBL] [Abstract][Full Text] [Related]
12. Circulating VEGF as a biomarker for diagnosis of ovarian cancer: a systematic review and a meta-analysis.
Liang B; He Q; Zhong L; Wang S; Pan Z; Wang T; Zhao Y
Onco Targets Ther; 2015; 8():1075-82. PubMed ID: 26028975
[TBL] [Abstract][Full Text] [Related]
13. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer.
Xi QP; Pu DH; Lu WN
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4536-4541. PubMed ID: 29131263
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Based Sandwich Assay for Measurement of Thymidine Kinase 1 in Serum of Cancerous Patients.
Nazari M; Gargari SLM; Sahebghadam Lotfi A; Rassaee MJ; Taheri RA
Biochemistry; 2019 May; 58(18):2373-2383. PubMed ID: 30900869
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.
Singh S; Kumar R; Kumar U; Kumari R
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667
[TBL] [Abstract][Full Text] [Related]
16. Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver.
Nisman B; Appelbaum L; Yutkin V; Nechushtan H; Hubert A; Uziely B; Pode D; Peretz T
Anticancer Res; 2016 Apr; 36(4):1791-7. PubMed ID: 27069161
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase 1 through the ages: a comprehensive review.
Bitter EE; Townsend MH; Erickson R; Allen C; O'Neill KL
Cell Biosci; 2020 Nov; 10(1):138. PubMed ID: 33292474
[TBL] [Abstract][Full Text] [Related]
18. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.
Zhu L; Liu Y; Chen G
Int J Clin Exp Med; 2014; 7(11):4000-7. PubMed ID: 25550908
[TBL] [Abstract][Full Text] [Related]
20. HSP90α combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma.
Tang Y; Li K; Cai Z; Xie Y; Tan X; Su C; Li J
Biomark Med; 2020 Jul; 14(10):869-878. PubMed ID: 32490681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
